Resistance MATTERS
Living with HIV (human immunodeficiency virus) means living with the risk of developing drug resistance. So when it comes to your treatment, think long term. PREZCOBIX® has a high genetic barrier to resistance. Find out what that means and talk to your healthcare provider.
Not a real patient.
Your first steps start here
After receiving an HIV diagnosis, it’s important to learn more about HIV and begin treatment as soon as possible.
What is HIV?
Human Immunodeficiency Virus, or HIV, is a virus that weakens the immune system by destroying cells that fight disease and infection. While there’s currently no cure, today’s treatments can help lower the amount of HIV in your system to a point where it is undetectable,* helping you to lead a long, healthy life.
*Undetectable is defined as the amount of HIV in the blood being below 50 copies/mL, meaning it cannot be measured by a lab test.
Benefits of starting treatment upon diagnosis
Helps decrease the chances of transmitting HIV
May lower your viral load to undetectable
Decreases health-related complications caused by HIV and other HIV-related illnesses
How PREZCOBIX® can help?
Once-daily PREZCOBIX® is two medications in one pill and is taken in combination with other HIV medications for the treatment of HIV-1 infection in adults. It contains 800 mg of darunavir and 150 mg of cobicistat. PREZCOBIX® may help you reach an undetectable* viral load.
*Undetectable is defined as a viral load of <50 copies/mL of the virus in your blood.
PREZCOBIX® may help:
- When used in combination with other HIV-1 medicines to treat HIV infection
- Support immune function by lowering how much HIV is in your blood (also called viral load)
- Increase the number of cells that fight infections in the body (your CD4-+T cell count)
PREZCOBIX® has a high genetic barrier to resistance
PREZCOBIX® is a treatment option with a high genetic barrier against resistance that might be right for you. Ask your healthcare provider about PREZCOBIX® and your risk for developing drug resistance. A medication with a high genetic barrier against resistance may help keep the virus undetectable*, even if the HIV has changed. Developing drug resistance can potentially cause treatment failure and limit future treatment options.
*Undetectable is defined as a viral load of <50 copies/mL of the virus in your blood.
PREZCOBIX® does not cure HIV-1 infection or AIDS, and you may still experience illnesses associated with HIV-1 infection. You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses.
Stop taking PREZCOBIX® and call your healthcare provider right away if you develop any skin changes with symptoms such as fever, tiredness, muscle or joint pain, blisters or skin lesions, mouth sores or ulcers, red or inflamed eyes like “pink eye” (conjunctivitis).
PREZCOBIX® may cause liver problems. Some people taking PREZCOBIX® may develop liver problems which may be life-threatening. Signs and symptoms of liver problems include dark (tea-colored) urine, yellowing of your skin or whites of your eyes, pale-colored stools (bowel movements), nausea, vomiting, pain or tenderness on your right side below your ribs, or loss of appetite. Tell your healthcare provider if you develop any of these symptoms.
Making PREZCOBIX® part of your daily life
Once-daily PREZCOBIX® is for:
Adult and pediatric patients who:
- Weigh at least 88 pounds (40 kg)
- Have taken or never taken HIV medicines in the past
- Do not have resistance associated with other HIV medications
PREZCOBIX® darunavir 800 mg/cobicistat 150 mg
PREZCOBIX® is a combination of two prescription medicines: darunavir, a type of HIV-1 medicine called a protease inhibitor, and cobicistat, a type of medicine that increases the amount of darunavir in your blood.
PREZCOBIX® is always taken in combination with other HIV medications for the treatment of HIV-1 infections in adult and pediatric patients.
PREZCOBIX® (darunavir/cobicistat) is a prescription medicine taken with other HIV medications for the treatment of HIV-1 infection in adult and pediatric patients. It is one treatment option in the class of HIV medicines known as protease inhibitors.
PREZCOBIX® dosing: one tablet taken once daily with food
PREZCOBIX® Combination Tablet: 800 mg of darunavir and 150 mg of cobicistat.
How should I take PREZCOBIX®?
Once a day in combination with other HIV medications
TIP: It is helpful to track when you need to take your medications every day.
At about the same time
every day
TIP: Take PREZCOBIX® with food every day on a regular dosing schedule. Missed doses can result in development of resistance.
With food
TIP: Try taking your medications while doing something you already do daily, like eating breakfast.
Do not change your dose of PREZCOBIX® or stop treatment without talking to your healthcare provider first. If you take too much PREZCOBIX®, call your healthcare provider or go to the nearest hospital emergency room right away.
Please read the Important Safety Information below for information on who should take PREZCOBIX® and talk to your healthcare provider to learn if PREZCOBIX® is right for you.
Paying for PREZCOBIX® with Janssen CarePath
Support for patients and their care partners
Once you and your doctor have decided that PREZCOBIX® is right for you, Janssen CarePath will help you find the resources you may need to get started and stay on track. We can help you understand your insurance coverage, give you information on treatment support, and identify options that may help make your treatment more affordable.
Need help?
Call a Janssen CarePath care coordinator at 866‐836‐0114, Monday–Friday, 8:00 AM–8:00 PM ET
Create a Janssen CarePath Account at MyJanssenCarePath.com or visit JanssenCarePath.com